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Effects of Fructose-Derived Advanced Glycation End Products on Acetylation of
Histones in the Brain
Abstract
Objective: The objective of this study was to determine the effects of fructose and their advanced
glycation end products (fru-AGES) on histone acetylation in microglia, the immune cells of the brain.
Significance: Fru-AGES primarily form as a result of non-enzymatic reactions between fructose and
proteins. One result is inflammation in the brain, which can be directly correlated to increased microglia
activity. Microglial activity has been shown to be associated with the acetylation of histones, resulting in a
change in transcription of inflammatory genes. Elucidation of a direct link between fructose, fru-AGES and
histone acetylation would increase understanding the pathophysiology of inflammatory disorders such as
Alzheimer’s disease.
Experimental Procedures: An immortalized rat microglial cell line was treated in vitro with control media,
fru-AGES or fructose. Histone acetylation was analyzed indirectly through activity of histone deacetlyase
(HDAC) using the HDAC Glo I/II Assay (Promega). Chemiluminescent product formation was measuring
with a spectrophotometer.
Results Obtained: Both treatments with fructose and fru-AGES showed an increase in HDAC activity
compared to control by up to 35% and 20%, respectively, correlating to a decrease in global histone
acetylation. This is contradictory to initial expectations, as a decrease in acetylation could result in a
decrease in transcription of genes . Despite causing an initial inflammatory response, fructose and fruAGES appear to suppress overall gene transcription.
Conclusion: Previous data show that exposure of microglia to fructose and fru-AGES results in a proinflammatory activated state. However, at the level of gene transcription, microglia may be desensitized
and less able to respond in the long term.
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Both treatments with fructose and fru-AGES
showed an increase in HDAC activity compared
to control by up to 80% and 40%, respectively,
correlating to a decrease in global histone
acetylation. This is contradictory to initial
expectations, as a decrease in acetylation could
result in a decrease in transcription of genes.
Despite increase in inflammatory cytokine gene
transcription (TNFalpha and C5), fructose and
fru-AGES appear to suppress overall gene
transcription.
This is reflected in TLR4
expression.



Previous data show that exposure of microglia
to fructose and fru-AGES results in a proinflammatory activated state. However, at the
level of gene transcription, microglia may be
desensitized and less able to respond in the
long term.



It is possible that gene transcription may be
altered earlier than 24 hours, and a 3 hour
treatment plan for the gene expression assay
may be beneficial to obtain in future
experiments.
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Figure 3: Histone deacetylase (HDAC) activity was
measured using the HDAC Glo I/II Assay Kit from
Promega Corporation. The assay utilizes the
reaction shown above to produce
chemiluminesence proportional to the level of HDAC
activity. The luminescence glow that can then be
measured using a spectrophotometer.6

Figure 4: A) Cells were treated with Fru-AGES and then the chemiluminesence
from the HDAC activity was measured 3 hours after treatment, showing up to a
20% increase. B) Cells were treated with fructose and the HDAC activity was
measured, showing up to a 37% increase. Increased HDAC activity would
correlate to an global decrease in histone acetylation after treatment with fructose
or fru-AGEs.
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Taqman Gene Expression

Figure 6: Expression of genes related to
microglial activation and inflammation was
measured. Three genes, tumor necrosis
factor alpha (TNFalpha), complement 5
(C5), and toll-like receptor 4 (TLR4) were
analyzed for expression after the addition
of increasing concentrations of fru-AGES
to microglia 24 hours prior. Results
determined an increase in both TNF alpha
and C5 (0.8 µg/µL and 0.2 µg/µL
treatments resulted in inconclusive data for
C5 expression). TLR4 gene expression
decreased slightly at the three highest
doses of fru-AGE.
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Figure 5: During qRT-PCR, the primers anneal
to the DNA, cleaving the probe containing the
gene expression markers, causing the probe
and quencher to be released from the reporter
and the DNA fragment, resulting in a signal
from the reporter5.

Gene expression analyses of TNF alpha and C5
showed up to a 6-fold increase in gene
expression with the treatment of fru-AGES 24
hours prior to analysis. The TLR4 gene
expression decreased after the treatment with
higher doses of fru-AGEs. This confirms that fruAGEs elicit an inflammatory response in
microglia, producing an activated phenotype.
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Methods
Fru-AGEs were produced by incubating fructose with
bovine serum albumin for 8 weeks at 37°C.3 An
immortalized rat microglial cell line was treated in vitro with
control media, fru-AGES or fructose. A quantitative realtime polymerase chain reaction (qRT-PCR) was performed
after the treatment of fru-AGES at a 24 hour time point at
concentrations of 0.8, 0.4, 0.2, and 0.1 µg/µL. The qRTPCR measured the gene expression of pro-inflammatory
markers such as complement 5 (C5) and tumor necrosis
factor α (TNFα) as well as cell-surface receptors such as
the toll-like receptor 4 (TLR4). Histone acetylation was
analyzed indirectly through activity of histone deacetlyase
(HDAC) using the HDAC Glo I/II Assay (Promega
Corporation), after 3 hours of treatment with fruAGEs or
fructose concentrations of 100, 50 , 25 or 10 mM.
Chemiluminescent product formation was measured with a
spectrophotometer and directly correlated with HDAC
activity.

Figure 2: Schematic of the production of Advanced Glycation
Endproducts (AGEs). This mechanism can be utilized in the
body with glucose and fructose when they come in contact with
a protein which produces the AGEs used in our experimental
procedure. These AGEs can then go on to produce
inflammation and tissue damage in the body.
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Using prior knowledge of glucose, fructose and fru-AGES,
the objective of this study was to determine the effects of
fructose and their advanced glycation end products (fruAGES) on histone acetylation in microglia, the immune
cells of the brain. In order to determine this, we studied
changes in inflammatory gene expression after microglia
were exposed to fru-AGES. In addition, we analyzed
histone acetylation in microglia via changes in histone
deacetylase enzyme activity after being exposed to
fructose and fru-AGES.
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Microglia are considered the immune cells of the central
nervous system (CNS). They are found throughout the
brain and are seen in a ramified, or branched form when in
their resting state, allowing them to monitor the tissue that
surrounds them. Microglia will change into an amoeboid
form when they come in contact with a stimulus that is
detrimental to the CNS. These triggers can include
damaged neuronal cells, foreign matter, plaques,
pathogens, or other inflammatory triggers (e.g., advanced
glycation end products (AGEs)).1 Fructose, or fruit sugar, is
a naturally occurring simple sugar that is often found as a
sweetener in many industrial food products such as soft
drinks.2 Fructose is highly prevalent in the average
everyday American diet.
With high consumption of
fructose, its reaction with proteins can cause the formation
of fructose advanced glycation end-products(Fru-AGES).
One result of the build up of these fru-AGES is
inflammation in the brain, which can be directly correlated
to increased microglia activity.3 Microglial activity has been
shown to be associated with the acetylation of histones, a
chemical modification that increases the accessibility of
DNA to transcriptional machinery.4 Increases in histone
acetylation is associated with increase gene transcription,
and vice versa. Elucidation of a direct link between
fructose, fru-AGES and histone acetylation would increase
understanding the pathophysiology of inflammatory
disorders such as Alzheimer’s disease.

Conclusions

Figure 1: When in
contact with
inflammatory signals,
activated microglia
release proinflammatory
molecules like
cytokines and
reactive oxygen
species. These
can be deleterious to
neurons in high
concentrations
suggesting the role in
neurodegeneration.
This figure is adapted
from Lull, 2007.1
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